Parkinson Study Group Selected Research

Parkinson Disease (Parkinson's Disease)

03/2007	Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage.
06/2006	Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
05/2006	Rasagiline improves quality of life in patients with early Parkinson's disease.
03/2006	Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease.
02/2006	Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease.
02/2006	A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
01/2006	Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.
02/2005	A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
01/2005	Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.
12/2004	Levodopa and the progression of Parkinson's disease.
09/2004	Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial.
07/2004	Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
04/2004	A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
12/2002	A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.
10/2002	Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
05/2002	Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
04/2002	Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
10/2001	Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease.
02/2001	A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
01/2001	Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
10/2000	Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Articles by Research Topic

Disease

21	Parkinson Disease (Parkinson's Disease) 03/2007 - 10/2000
2	Parkinsonian Disorders (Parkinsonism) 05/2002 - 11/2001
1	Disease Progression 06/2006
1	Dyskinesias (Dyskinesia) 10/2001

Drug/Important Bio-Agent (IBA)

11	Levodopa (L Dopa)FDA LinkGeneric 03/2007 - 10/2000
7	pramipexol (pramipexole)FDA LinkGeneric 03/2007 - 10/2000
4	rasagiline (Azilect)FDA Link 05/2006 - 12/2002
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 04/2002 - 11/2001
2	remacemideIBA 10/2001 - 02/2001
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 03/2006
1	Nicotinic AgonistsIBA 02/2006
1	SIB 1508YIBA 02/2006
1	etilevodopaIBA 02/2006
1	TEMPOIBA 12/2002
1	coenzyme Q10 (CoQ10)IBA 10/2002
1	Selegiline (E250)FDA LinkGeneric 05/2002
1	Clozapine (Clozaril)FDA LinkGeneric 01/2001